Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (141-150 of 311) with videos related to

Pageof 32
Sort By:
Scandinavian Journal of Haematology|October 1, 1977
ATYPICAL SURFACE MAKER CHARACTERISTICS IN A T-cell lymphomaG Janossy, B A McVerry, A H Goldstone, et al.
British Journal of Haematology|April 1, 1996
Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patternsR E Gale, C Bunch, D J Moir, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2001
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usageS J Bradley, A L Wilson, M C Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for LymphomaH C Schouten, P Colombat, L F Verdonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry dataR Chopra, A H Goldstone, R Pearce, et al.
Clinical and Laboratory Haematology|January 1, 1986
A rise in the percentage of large unstained cells in the peripheral blood determined by the Hemalog D90 automated differential counter is a feature of impending myeloid engraftment following bone marrow transplantationP J Martin, C C Anderson, H M Jones, et al.
British Journal of Cancer|January 26, 2000
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patientsM J Watts, S J Ings, D Leverett, et al.
Leukemia|May 1, 1992
Cytokine induction of leucocyte adhesion molecule-1 (LAM- 1) expression on chronic lymphocytic leukaemia cellsA P Jewell, K L Yong, C P Worman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
British Journal of Haematology|October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivoA P Jewell, C P Worman, P M Lydyard, et al.
Pageof 32

Showing results (141-150 of 311) with videos related to

Sort By:
Pageof 32
Scandinavian Journal of Haematology|October 1, 1977
ATYPICAL SURFACE MAKER CHARACTERISTICS IN A T-cell lymphomaG Janossy, B A McVerry, A H Goldstone, et al.
British Journal of Haematology|April 1, 1996
Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patternsR E Gale, C Bunch, D J Moir, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2001
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usageS J Bradley, A L Wilson, M C Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for LymphomaH C Schouten, P Colombat, L F Verdonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry dataR Chopra, A H Goldstone, R Pearce, et al.
Clinical and Laboratory Haematology|January 1, 1986
A rise in the percentage of large unstained cells in the peripheral blood determined by the Hemalog D90 automated differential counter is a feature of impending myeloid engraftment following bone marrow transplantationP J Martin, C C Anderson, H M Jones, et al.
British Journal of Cancer|January 26, 2000
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patientsM J Watts, S J Ings, D Leverett, et al.
Leukemia|May 1, 1992
Cytokine induction of leucocyte adhesion molecule-1 (LAM- 1) expression on chronic lymphocytic leukaemia cellsA P Jewell, K L Yong, C P Worman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
British Journal of Haematology|October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivoA P Jewell, C P Worman, P M Lydyard, et al.
Pageof 32